Azimova M.R., Zhernakova J.V. Possibilities of a new glucagon-like peptide-1 receptor agonist Semaglutide in improving left ventricular diastolic function in a patient with arterial hypertension and type 2 diabetes mellitu. Systemic Hypertension. 2021;18(4):186-192. (In Russ.) https://doi.org/10.26442/2075082X.2021.4.201305
Email this article (Login required)
Email the author (Login required) OOO InterMedservice
Address: 121069, Russia, Moscow, Stolovy Lane, 6
Tel.: +7 (985) 763-98-00
e-mail: og@intermed.services
The media outlet is registered with the Federal Service for Supervision of Communications, Information Technology, and Mass Media (Roskomnadzor). Registration number and date of the decision on media registration: series EL No. FS 77 - 83918 dated 12.09.2022.
16+
Processing of personal data
